Your cart is currently empty!

ISO 22441:2022
ISO 22441:2022 Sterilization of health care products – Low temperature vaporized hydrogen peroxide – Requirements for the development, validation and routine control of a sterilization process for medical devices
CDN $351.00
Description
1.1  Inclusions
1.1.1    This document provides requirements for the development, validation and routine monitoring and control of a low temperature sterilization process for medical devices using vaporized hydrogen peroxide (VH2O2) as the sterilizing agent.
1.1.2    This document is intended to be applied by process developers, manufacturers of sterilization equipment, manufacturers of medical devices to be sterilized, organizations performing process validation of VH2O2 sterilization, and organizations responsible for sterilizing medical devices.
NOTE      VH2O2 sterilizers can be used in both health care and industrial facilities, and this document acknowledges the similarities and differences between the two applications.
1.2  Exclusions
1.2.1    Processes that use other sterilizing agents, or hydrogen peroxide solution in combination with other chemicals as the sterilizing agent are not addressed in this document.
NOTE      See ISO 14937 for guidance on validation of such processes.
1.2.2    This document does not specify requirements for development, validation and routine control of a process for inactivating the causative agents of spongiform encephalopathies, e.g. scrapie, bovine spongiform encephalopathy and Creutzfeldt-Jakob disease. Specific recommendations have been produced in particular countries for the processing of materials potentially contaminated with these agents.
NOTE      Some VH2O2 sterilizers have processes that demonstrate some level of inactivation of the causative agents of spongiform encephalopathies, e.g. scrapie, bovine spongiform encephalopathy and Creutzfeldt-Jakob Disease. However, this inactivation is process, cycle, and test protocol specific, therefore this inactivation is outside the scope of this document, and no specific test methods are provided (see [14], [26], and [30] for more information).
1.2.3    This document does not specify requirements for designating a medical device as sterile.
NOTE      See for example EN 556–1 or ANSI/AAMI ST67.
1.2.4    This document does not specify requirements for occupational safety associated with the design and operation of VH2O2 sterilization equipment.
NOTE      For further information on safety, see examples in the Bibliography. National or regional regulations can also exist.
1.2.5    This document does not apply to the contents of contained product, i.e. product for which the environment within the sterilizer chamber during any stage of the sterilization process does not come into direct contact with the product, such as a solution in a sealed bottle.
1.2.6    This document does not cover hydrogen peroxide decontamination systems for use in rooms, enclosures or environmental spaces.
NOTE      These decontamination systems operate at ambient conditions (e.g. temperature and pressure) and in general utilise an approach that is different to that of VH2O2 sterilization processes addressed in this document.
Edition
1
Published Date
2022-08-26
Status
PUBLISHED
Pages
79
Format 
Secure PDF
Secure – PDF details
- Save your file locally or view it via a web viewer
- Viewing permissions are restricted exclusively to the purchaser
- Device limits - 3
- Printing – Enabled only to print (1) copy
See more about our Environmental Commitment

Abstract
1.1  Inclusions
1.1.1    This document provides requirements for the development, validation and routine monitoring and control of a low temperature sterilization process for medical devices using vaporized hydrogen peroxide (VH2O2) as the sterilizing agent.
1.1.2    This document is intended to be applied by process developers, manufacturers of sterilization equipment, manufacturers of medical devices to be sterilized, organizations performing process validation of VH2O2 sterilization, and organizations responsible for sterilizing medical devices.
NOTE      VH2O2 sterilizers can be used in both health care and industrial facilities, and this document acknowledges the similarities and differences between the two applications.
1.2  Exclusions
1.2.1    Processes that use other sterilizing agents, or hydrogen peroxide solution in combination with other chemicals as the sterilizing agent are not addressed in this document.
NOTE      See ISO 14937 for guidance on validation of such processes.
1.2.2    This document does not specify requirements for development, validation and routine control of a process for inactivating the causative agents of spongiform encephalopathies, e.g. scrapie, bovine spongiform encephalopathy and Creutzfeldt-Jakob disease. Specific recommendations have been produced in particular countries for the processing of materials potentially contaminated with these agents.
NOTE      Some VH2O2 sterilizers have processes that demonstrate some level of inactivation of the causative agents of spongiform encephalopathies, e.g. scrapie, bovine spongiform encephalopathy and Creutzfeldt-Jakob Disease. However, this inactivation is process, cycle, and test protocol specific, therefore this inactivation is outside the scope of this document, and no specific test methods are provided (see [14], [26], and [30] for more information).
1.2.3    This document does not specify requirements for designating a medical device as sterile.
NOTE      See for example EN 556–1 or ANSI/AAMI ST67.
1.2.4    This document does not specify requirements for occupational safety associated with the design and operation of VH2O2 sterilization equipment.
NOTE      For further information on safety, see examples in the Bibliography. National or regional regulations can also exist.
1.2.5    This document does not apply to the contents of contained product, i.e. product for which the environment within the sterilizer chamber during any stage of the sterilization process does not come into direct contact with the product, such as a solution in a sealed bottle.
1.2.6    This document does not cover hydrogen peroxide decontamination systems for use in rooms, enclosures or environmental spaces.
NOTE      These decontamination systems operate at ambient conditions (e.g. temperature and pressure) and in general utilise an approach that is different to that of VH2O2 sterilization processes addressed in this document.
Previous Editions
Can’t find what you are looking for?
Please contact us at:
Related Documents
-
ISO 21387:2020 Sterilization of medical devices – Guidance on the requirements for the validation and routine processing of ethylene oxide sterilization processes using parametric release
0 out of 5CDN $173.00 Add to cart -
ISO 19930:2017 Guidance on aspects of a risk-based approach to assuring sterility of terminally sterilized, single-use health care product that is unable to withstand processing to achieve maximally a sterility assurance level of 10-6
0 out of 5CDN $233.00 Add to cart -
ISO 11139:2024 Sterilization of health care products – Vocabulary of terms used in sterilization and related equipment and process standards – Amendment 1: Amended and additional terms and definitions
0 out of 5CDN $32.00 Add to cart -
ISO 11737:2023 Sterilization of health care products – Microbiological methods – Part 3: Bacterial endotoxin testing
0 out of 5CDN $351.00 Add to cart